Literature DB >> 21111003

In-depth analysis of G-to-A hypermutation rate in HIV-1 env DNA induced by endogenous APOBEC3 proteins using massively parallel sequencing.

Stefanie A Knoepfel1, Francesca Di Giallonardo, Martin Däumer, Alexander Thielen, Karin J Metzner.   

Abstract

Some APOBEC3 proteins cause G-to-A hypermutation in HIV-1 DNA when the accessory viral protein Vif is absent or non-functional. So far, cloning and sequencing has been performed to study G-to-A hypermutation. This is time-consuming and labour-intensive especially in the context of in vivo investigations where the number of hypermutated sequences can be very low. Thus, a massively parallel sequencing protocol has been developed for in-depth analysis of G-to-A hypermutation using the 454 pyrosequencing FLX system. Part of HIV-1 env was amplified and pyrosequenced after two rounds of infection in T cell lines and PBMCs using HIV-1 NL4-3Δvif. Specific criteria were applied to cope with major technical challenges: (1) the inclusion of hypermutated sequences, (2) the high genome diversity of HIV-1 env, and (3) the exclusion of sequences containing frameshift errors caused by pyrosequencing. In total, more than 140,000 sequences were obtained. 1.3-6.5% of guanines were mutated to adenine, most frequently in the GG dinucleotide context, the preferred deamination site of APOBEC3G. Non-G-to-A mutations occurred only in low frequencies (<0.6%). Single hypermutated sequences contained up to 24 G-to-A mutations. Overall, massively parallel sequencing is a very useful tool for in-depth analysis of G-to-A hypermutation in HIV-1 DNA induced by APOBEC3 proteins.
© 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21111003     DOI: 10.1016/j.jviromet.2010.11.016

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  10 in total

1.  Comparison of a high-resolution melting assay to next-generation sequencing for analysis of HIV diversity.

Authors:  Matthew M Cousins; San-San Ou; Maria J Wawer; Supriya Munshaw; David Swan; Craig A Magaret; Caroline E Mullis; David Serwadda; Stephen F Porcella; Ronald H Gray; Thomas C Quinn; Deborah Donnell; Susan H Eshleman; Andrew D Redd
Journal:  J Clin Microbiol       Date:  2012-07-11       Impact factor: 5.948

2.  Persistence of SIV in the brain of SIV-infected Chinese rhesus macaques with or without antiretroviral therapy.

Authors:  Stefanie Perez; Ann-Marie Johnson; Shi-Hua Xiang; Jian Li; Brian T Foley; Lara Doyle-Meyers; Antonito Panganiban; Amitinder Kaur; Ronald S Veazey; Yuntao Wu; Binhua Ling
Journal:  J Neurovirol       Date:  2017-11-27       Impact factor: 2.643

3.  Hypermutation of ApoB mRNA by rat APOBEC-1 overexpression mimics APOBEC-3 hypermutation.

Authors:  Zhigang Chen; Thomas L Eggerman; Alexander V Bocharov; Irina N Baranova; Tatyana G Vishnyakova; Roger J Kurlander; Gyorgy Csako; Amy P Patterson
Journal:  J Mol Biol       Date:  2012-02-09       Impact factor: 5.469

Review 4.  Deep sequencing: becoming a critical tool in clinical virology.

Authors:  Miguel E Quiñones-Mateu; Santiago Avila; Gustavo Reyes-Teran; Miguel A Martinez
Journal:  J Clin Virol       Date:  2014-06-24       Impact factor: 3.168

5.  Reassessment of murine APOBEC1 as a retrovirus restriction factor in vivo.

Authors:  Bradley S Barrett; Kejun Guo; Michael S Harper; Sam X Li; Karl J Heilman; Nicholas O Davidson; Mario L Santiago
Journal:  Virology       Date:  2014-10-07       Impact factor: 3.616

6.  APOBEC3G expression and hypermutation are inversely associated with human immunodeficiency virus type 1 (HIV-1) burden in vivo.

Authors:  Yordanka Kourteva; MariaPia De Pasquale; Tara Allos; Chara McMunn; Richard T D'Aquila
Journal:  Virology       Date:  2012-05-12       Impact factor: 3.616

7.  Challenges and opportunities in estimating viral genetic diversity from next-generation sequencing data.

Authors:  Niko Beerenwinkel; Huldrych F Günthard; Volker Roth; Karin J Metzner
Journal:  Front Microbiol       Date:  2012-09-11       Impact factor: 5.640

8.  Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response.

Authors:  Diana S Smith; Kejun Guo; Bradley S Barrett; Karl J Heilman; Leonard H Evans; Kim J Hasenkrug; Warner C Greene; Mario L Santiago
Journal:  PLoS Pathog       Date:  2011-10-06       Impact factor: 6.823

9.  Emergence of CXCR4-tropic HIV-1 variants followed by rapid disease progression in hemophiliac slow progressors.

Authors:  Tsunefusa Hayashida; Kiyoto Tsuchiya; Yoshimi Kikuchi; Shinichi Oka; Hiroyuki Gatanaga
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

10.  Absence of A3Z3-Related Hypermutations in the env and vif Proviral Genes in FIV Naturally Infected Cats.

Authors:  Lucía Cano-Ortiz; Dennis Maletich Junqueira; Juliana Comerlato; André Zani; Cristina Santos Costa; Paulo Michel Roehe; Ana Cláudia Franco
Journal:  Viruses       Date:  2018-05-31       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.